Evaluation of Stress Sensitivity and Hyperemotivity in Epilepsy Compared to and a Group of Healthy Volunteers

NCT ID: NCT03464370

Last Updated: 2018-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-08

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recently, a possible subtype of temporal lobe epilepsy (TLE) has been proposed: this subtype presents ipsilateral amygdala enlargement (AE) without any other lesion. However, little is known about its clinical and psychiatric phenotype. The amygdala seems to play a major role in stress related disorders (including perception of stress). The hypothesis in this study is that patients with TLE-AE more frequently report emotional distress as a seizure-precipitating factor than any other epileptic patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

TLE-AE could concern 16 to 64 % of the TLE with "negative" MRI (Beh et al., 2016).

TLE-AE patients may suffer from anxiety and depression (Lv et al, 2014). In clinical practice, it has been also identified an emotional vulnerability in these patients, as they report more frequently a high sensitivity to emotional distress than other epileptic patients. They also report a change in their affect intensity or a hyperemotivity, which appeared at the onset of their epilepsy. Lanteaume et al. have linked some TLE with an increased emotional vulnerability (Emo-TLE): these TLE patients reported stress factors precipitating their seizures. They found that the Emo-TLE group was characterized by an attentional bias toward threatening stimuli versus neutral stimuli, and that this bias was noticed neither in the TLE group without emotional vulnerability nor in healthy volunteers. But they did not study amygdala structure in each group.In the large database of the Toulouse University Hospital, screening was done to retrospectively collect TLE patients with AE identified on MRI. This large database has served to establish a reading grid in order to help the visual identification of an AE.The investigators propose to these patients them a series of validated scales to test:

* The impact of emotional stress factors for precipitating seizures
* The perception of stress (PSS-10).
* Psychiatric comorbidities (anxiety, depression, post-traumatic stress disorder, emotional lability…).

The study also propose cognitive tasks to search for an attentional bias towards threatening stimuli (Emotional Stroop and modified probe test). After this, the study will assess their emotional subjective responses (valence, arousal, avoidance) through a task during which they are presented with short movies that elicit six different emotions. At the same time, the measure of the variations of their neurovegetative system in terms of blood pressure, heart rate variability and electrodermal skin conductance variability will be done.

For each TLE-AE patient, additional healthy controls will be matched (2 for testing the primary outcome, 3 for the secondary outcomes).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This pilot study is prospective, monocentric, epidemiologic, case control
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TLE-AE Group

30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.

Group Type EXPERIMENTAL

Measure of emotional stressors

Intervention Type OTHER

For the Epileptic Group

* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales

For the healthy volunteers group :

* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment

Non AE epileptic Group

30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.

Group Type ACTIVE_COMPARATOR

Measure of emotional stressors

Intervention Type OTHER

For the Epileptic Group

* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales

For the healthy volunteers group :

* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment

Extra-temporal epilepsy Group

30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors and then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.

Group Type ACTIVE_COMPARATOR

Measure of emotional stressors

Intervention Type OTHER

For the Epileptic Group

* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales

For the healthy volunteers group :

* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment

Healthy volunteers Group

30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors

Group Type ACTIVE_COMPARATOR

Measure of emotional stressors

Intervention Type OTHER

For the Epileptic Group

* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales

For the healthy volunteers group :

* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measure of emotional stressors

For the Epileptic Group

* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales

For the healthy volunteers group :

* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- For all epileptic patients: Age between 18 and 65. Epilepsy (TLE or not) followed by an epileptologist.

\- For TLE-AE: An AE identified on the MRI by an expert neuroradiologist. MRI must be less than one year.

\- For non AE epileptic patients: No AE reported in the MRI by an expert neuroradiologist.

Exclusion Criteria

* Any mental disorder.
* Any diabetes
* Beta-blockers
* Neuroleptics
* Any neurologic diseases for the healthy volunteers.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie DENUELLE, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Toulouse

Toulouse, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marie DENUELLE, MD

Role: CONTACT

5 61 77 79 24 ext. 33

Isabelle Olivier, PhD

Role: CONTACT

5 61 77 70 51 ext. 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie DENUELLE, MD

Role: primary

05 61 77 79 24 ext. 33

Isabelle Olivier, PhD

Role: backup

5 61 77 70 51 ext. 33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02853-50

Identifier Type: OTHER

Identifier Source: secondary_id

RC31/17/0276

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.